|
|
Updated Wednesday, April 29, 2009 5:46 pm TWN, By Deborah Kuo, CNA Local pharmaceutical companies prepare to develop swine flu vaccineYeh said at the Legislative Yuan that the Department of Health (DOH) has also instructed the non-profit National Health Research Institute (NHRI) to prepare for developing the vaccine. He said the NHRI is capable of producing vaccine in emergency situations and that an expanded vaccine plant run by Adimmune Corp., also known as Kuo Kwang Biotechnology, is expected to be inaugurated by June. The Adimmune vaccine plant, which will be the largest of its kind in Asia with a maximum annual capacity of 30 million doses of vaccine, will allow production of human vaccine against swine flu to be significantly ramped up, Yeh noted. Noting that the World Health Organization (WHO) is working on a global H1NI vaccine production plan, Yeh said the country will take part in the global action in line with WHO instructions. Subscribe to The China Post and save 25%. Click here |
| |||||||||||||||